The process is very simple, for a condition like ME/CFS, we compute the expected number of samples reporting this bacteria (based on people without Long COVID) and compare it to the actual number seen. This can be used to compute a statistical value called Chi-Square (χ²), This is then used to compute the chance of it happening at random. This is possible because we have over 3600 samples from some labs and thus able to detect things better.
Actual example:
- Tetragenococcus halophilus – Species reported by Biomesight
- Expected to see 15
- Actually seen 59
- In other words almost 4x more common than expected. The probability is
- 1.68054690853052E-30
- or 1 chance in 600,000,000,000,000,000,000,000,000,000 of happening at random.
- This suggests that we should reduce it to remedy Long COVID [with the other 92 bacteria involved]
Biomesight and Ombre identifies bacteria using different methodologies so often give different names and amounts. For background on this lack of standardization, see The taxonomy nightmare before Christmas…
The data below is for samples marked with “Official Diagnosis: COVID19 (Long Hauler)”. Only Biomesight had sufficient data to get patterns.
Long COVID appears similar to ME/CFS, so comparing results below to those in this post: Bacteria Shifts that are Statistically Significant for ME/CFS, may provide further insight.
Unlike some conditions shown below, it is not just one bacteria involved but combinations.
- Peptic ulcer disease: Helicobacter pylori
- Tetanus: Clostridium tetani
- Typhoid fever: Salmonella typhi
- Diphtheria: Corynebacterium diphtheriae
- Syphilis: Treponema pallidum
- Cholera: Vibrio cholerae
- Leprosy: Mycobacterium leprae
- Tuberculosis: Mycobacterium tuberculosis
- Sinusitis: Corynebacterium tuberculostearicum
Biomesight Data
We have more data from Biomesight which means better (more) detection of significant bacteria. The data is very different from ME/CFS. We have 16 bacteria too high and 61 bacteria too low. With ME/CFS and the same lab, we have 12 bacteria that are too low and 116 bacteria that are too high.
We have some commonalities
- Bifidobacterium adolescentis is too low for both Long COVID and ME/CFS
- Lactobacillus crispatus is too high
- Another probiotic genus, Lactococcus, is also too high
Tax_Name | Tax_Rank | Expected | Observed | Shift | Probability |
50 kb inversion clade | clade | 77.3 | 54 | Too Low | 0.008002 |
Acinetobacter antiviralis | species | 13.7 | 24 | Too High | 0.00524 |
Acinetobacter johnsonii | species | 18.1 | 30 | Too High | 0.004944 |
Actinopolyspora | genus | 62.3 | 35 | Too Low | 0.001477 |
Actinopolysporaceae | family | 62.3 | 35 | Too Low | 0.001477 |
Actinopolysporales | order | 62.3 | 35 | Too Low | 0.001477 |
Aeromonadaceae | family | 81.8 | 57 | Too Low | 0.006169 |
Alkalibacterium | genus | 112.5 | 81 | Too Low | 0.005041 |
Anaerococcus lactolyticus | species | 23.2 | 38 | Too High | 0.002205 |
Anaerococcus prevotii | species | 20.1 | 33 | Too High | 0.003987 |
ant, tsetse, mealybug, aphid, etc. endosymbionts | clade | 82.7 | 58 | Too Low | 0.006624 |
Bifidobacterium adolescentis | strain | 103.5 | 65 | Too Low | 0.002509 |
Chromatium | genus | 61.3 | 34 | Too Low | 0.00355 |
Chromatium weissei | species | 61.2 | 34 | Too Low | 0.00355 |
Chromobacterium group | no rank | 15.3 | 26 | Too High | 0.006127 |
Citrobacter | genus | 64.1 | 41 | Too Low | 0.003939 |
Clostridium neonatale | species | 13.7 | 25 | Too High | 0.002196 |
Cohnella | genus | 108.6 | 78 | Too Low | 0.005067 |
Coraliomargarita | genus | 96.4 | 70 | Too Low | 0.00718 |
Coraliomargarita akajimensis | species | 96.3 | 70 | Too Low | 0.007357 |
core genistoids | clade | 77.3 | 54 | Too Low | 0.008002 |
Corynebacterium striatum | species | 16.9 | 28 | Too High | 0.006887 |
Crotalarieae | tribe | 77.3 | 54 | Too Low | 0.008002 |
Deferribacteraceae | family | 98.2 | 71 | Too Low | 0.006129 |
Deferribacterales | order | 98.2 | 71 | Too Low | 0.006129 |
Deferribacteres | class | 98.2 | 71 | Too Low | 0.006129 |
Deferribacterota | phylum | 98.2 | 71 | Too Low | 0.006129 |
Desulfallaceae | family | 148.6 | 108 | Too Low | 0.001472 |
Enterobacter cloacae complex | species group | 86.4 | 60 | Too Low | 0.004516 |
Enterobacter hormaechei | species | 85.4 | 57 | Too Low | 0.002134 |
Enterobacteriaceae incertae sedis | no rank | 82.7 | 58 | Too Low | 0.006624 |
Erysipelothrix inopinata | species | 54.2 | 21 | Too Low | 4.45E-05 |
Fabaceae | family | 77.3 | 54 | Too Low | 0.008002 |
Fabales | order | 77.3 | 54 | Too Low | 0.008002 |
fabids | clade | 77.3 | 54 | Too Low | 0.008002 |
genistoids sensu lato | clade | 77.3 | 54 | Too Low | 0.008002 |
Granulicella | genus | 16.4 | 29 | Too High | 0.001841 |
Granulicella tundricola | species | 16.2 | 29 | Too High | 0.00148 |
Hallella bergensis | species | 20.1 | 33 | Too High | 0.003987 |
Lactobacillus crispatus | species | 26.5 | 43 | Too High | 0.001406 |
Lactococcus | genus | 161.5 | 201 | Too High | 0.001877 |
Leptospira | genus | 89.5 | 61 | Too Low | 0.002559 |
Leptospira licerasiae | species | 89.4 | 61 | Too Low | 0.002701 |
Leptospiraceae | family | 89.5 | 61 | Too Low | 0.002559 |
Leptospirales | order | 89.5 | 61 | Too Low | 0.002559 |
Lysinibacillus | genus | 51.5 | 32 | Too Low | 0.006618 |
Lysinibacillus parviboronicapiens | species | 50.4 | 29 | Too Low | 0.002564 |
Macrococcus | genus | 118.9 | 89 | Too Low | 0.006111 |
Microbacteriaceae | family | 99.5 | 72 | Too Low | 0.005912 |
Moorella group | norank | 152.6 | 188 | Too High | 0.004132 |
Oxalobacter | genus | 130.9 | 99 | Too Low | 0.005356 |
Oxalobacter vibrioformis | species | 94.9 | 65 | Too Low | 0.007793 |
Papilionoideae | subfamily | 77.3 | 54 | Too Low | 0.008002 |
Peptoniphilus lacrimalis | species | 51.8 | 72 | Too High | 0.004884 |
Piscirickettsiaceae | family | 51.5 | 29 | Too Low | 0.007262 |
Psychrobacter | genus | 138.9 | 99 | Too Low | 0.001332 |
Psychrobacter glacialis | species | 75.1 | 51 | Too Low | 0.00545 |
rosids | clade | 77.3 | 54 | Too Low | 0.008002 |
Rothia | genus | 77.3 | 54 | Too Low | 0.008002 |
Rothia mucilaginosa | species | 64.1 | 40 | Too Low | 0.002631 |
Sporotomaculum | genus | 148.6 | 108 | Too Low | 0.001472 |
Sporotomaculum syntrophicum | species | 146.7 | 107 | Too Low | 0.001751 |
Streptococcus massiliensis | species | 53.6 | 34 | Too Low | 0.007353 |
Syntrophobacteraceae | family | 118.3 | 83 | Too Low | 0.00291 |
Tetragenococcus halophilus | species | 18.0 | 59 | Too High | 3.63E-22 |
Thiomicrospira | genus | 43.7 | 26 | Too Low | 0.007396 |
Tolumonas | genus | 80.7 | 55 | Too Low | 0.004169 |
Tolumonas auensis | species | 79.9 | 54 | Too Low | 0.003748 |
Trabulsiella | genus | 59.1 | 37 | Too Low | 0.004074 |
Vagococcus | genus | 99.2 | 72 | Too Low | 0.00718 |
Varibaculum cambriense | species | 17.3 | 30 | Too High | 0.002302 |
Bottom Line
My personal view is that this pattern is not unexpected. ME/CFS microbiome is typically after years of the dysbiosis microbiome evolving. With Long COVID, we have the microbiome still trying to stabilize.
- Bif. Adolescentis
And all Lactobacillus and Lactococcus probiotics should be avoided.
The above information will be eventually integrated into Microbiome Prescription suggestions expert system. The purpose is to first identify the bacteria of concern.
The following bacteria were reported by 2 or 3 of the ME/CFS analysis and the same shift seen with Long COVID.
Anaerococcus murdochii | species — sibling high in ME/CFS |
Peptoniphilus lacrimalis | species – HIGH EVERYWHERE |
Varibaculum | genus – HIGH EVERYWHERE |
Varibaculum, particularly Varibaculum cambriense, has been identified as a potential pathogen associated with various human infections, especially in skin and soft tissues26. This anaerobic, gram-positive bacterium was first described in 2003 and has since been isolated from several clinical cases2.
A new species, Varibaculum timonense, has been isolated from human stool samples, indicating that the genus Varibaculum may have a broader presence in the human microbiome than previously recognized3.
While Varibaculum species are not yet widely known pathogens, their isolation from various infection sites suggests they may play a more significant role in human health than currently understood. Further research is needed to fully elucidate the pathogenic potential and clinical importance of these bacteria.